Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
JACKSONVILLE, Fla., Oct. 4 /PRNewswire-FirstCall/ -- An affiliate of Phlo Corporation (OTC: PHLC) (the 'Company') announced today that it has hired as its Chief Marketing Officer Rudy Prajza, who has extensive worldwide expertise directing the marketing and communications programs of major international corporations.
Mr. Prajza was the Executive Vice President of D'Arcy Advertising in London (during which he was the Global Managing Director of the Mars Inc. account worldwide) and was Executive Vice President of McCann-Erickson, during which period he was the Worldwide Account Director for The Coca-Cola Company. Mr. Prajza's professional experience extends across virtually every business sector - charities, packaged goods, technology, automotive, manufacturing, fashion, resources, banking, government, tourism. His direct working experience includes such internationally-recognized organizations as the Special Olympics, Coca-Cola, Nestle, Mars, L'Oreal, Johnson & Johnson, Warner Lambert, UniLever, Exxon, Hong Kong Bank, TD Bank, Molson Breweries, Toronto Tourism, Ontario Hydro, Sears, Kodak, General Motors, General Electric, Columbia Pictures, Wedgewood, Microsoft, IBM and others.
'This is a major league hire - Rudy's experience says it all,' said James B. Hovis, CEO of the Company.
AQUISS(TM) features the Company's Instant Nano Hydration and Cell Armor technologies, providing instant, direct delivery of rehydration and cell- repair-and-protection payloads into the bloodstream beginning through the membranes of the mouth. These Instant Nano Hydration and Cell Armor technologies help provide sustained wellness necessary for life's performances and vigorous longevity. In addition, the Company's nano-encapsulation technology prevents the destruction of its active payloads in the stomach.
Phlo is a biotechnology company and a manufacturer and marketer of products (primarily liquids) containing patented and patent-pending biotechnologies. Phlo is focusing its technology generation and acquisition efforts on those technologies related to enhancing cognition and personal performance, reducing the effects of aging, and preventing or ameliorating cancer.
Certain statements made herein that are not historical constitute 'forward-looking' statements within the meaning of the Private Litigation Reform Act of 1995 and may contain words such as 'anticipate,' 'believe,' 'expect,' 'future,' 'may,' 'will,' 'should,' 'plan,' 'projected,' 'intend,' and similar expressions to identify such forward-looking statements. Such statements are based on a number of assumptions and on information and estimates supplied to Phlo Corporation by sources currently available to it. Such assumptions and estimates are subject to uncertainties, contingencies, and other factors, many of which are beyond Phlo Corporation's control. Actual results may differ materially from the statements set forth above.
SOURCE Phlo Corporation
Source: PR Newswire (October 4, 2007 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
News 
Market Data 
Discover 
